Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | CXCR4 in Waldenström’s macroglobulinemia

Zachary Hunter • 14 Sep 2019
IMW 2019
Rare Diseases Waldenström’s Macroglobulinemia

Zachary Hunter, PhD, of Dana-Farber Cancer Institute, Boston, MA, discusses the genomic basis of Waldenström’s Macroglobulinemia at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Zachary Hunter

1:12
Flow cytometry can detect changes in protein expression throughout the evolution of WM
Zachary Hunter • 10 Dec 2023
1:33
Quantifying mutant MYD88 expression to track disease burden in WM
Zachary Hunter • 10 Dec 2023
1:26
Epigenetic alterations underlying the distinct gene expression profiles in WM
Zachary Hunter • 10 Dec 2023
2:31
Gene expression profiles in subtype characterization and disease evolution of WM
Zachary Hunter • 10 Dec 2023

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals